Fingerprint
Dive into the research topics of 'Phase I trial of hedgehog pathway inhibitor vismodegib (GDC-0449) in patients with refractory, locally advanced or metastatic solid tumors'. Together they form a unique fingerprint.- Sort by
- Weight
- Alphabetically